̽»¨¾«Ñ¡

Cancer Research UK Therapeutic Catalyst Awards were launched in late 2021 and have been a great success. The scheme operates as a collaborative venture between research scientists and drug discoverers within Cancer Research Horizons to accelerate the translation of novel ideas for therapeutic discovery. Awards can be up to £250,000 to support a 12–18-month proposal. There are 3 rounds of applications per year held in February, June and October. 

Next expression of interest deadline: 6 June 2025. 

Childhood Cancer Therapeutic Catalyst accelerates the translation of discovery research into novel therapeutics. It seeks projects with strong potential to deliver novel therapeutics for children and young people with cancer. This scheme aims to de-risk early projects to facilitate further drug discovery research, funding, or partnering. 

Successful projects will receive up to £250k for up to 18 months. 

The Data Catalyst aims to maximise the impact of cancer datasets that may have commercial value. The scheme does this through providing funding and support to help researchers make these datasets more accessible and usable by third parties. 

The end goal is to produce a high-quality cancer dataset that adheres to FAIR principles (findable, accessible, interoperable, and reusable) and can be made available to third parties for further research and product development.

The Seed Fund builds on 25 years of creating and building successful start-ups. Managed by Cancer Research Horizons' dedicated Ventures team, the fund helps bridge one of the most challenging stages of start-up creation: attracting early-stage risk capital.  

Set up with a cornerstone investment of £15m from Cancer Research UK, the fund now totals more than £25m following a £10m donation from the Garfield Weston Foundation and other donations from entrepreneurially minded philanthropists. The target is to reach £30m by the end of 2025. The investment remit includes therapeutics, diagnostics, ̽»¨¾«Ñ¡ devices and data-driven and AI solutions.

The next Q&A drop-in session with Cancer Research Horizons will be held on 29 April 2025, 12:30 - 13:30h, online.

During this session, you will get the chance to ask any questions on the grants or other opportunities to work with Cancer Research Horizons. 

No registration is needed, just follow the to join the session!

Date of webinar: 16th May 2024, 14:00 – 15:00 (CET)

In this webinar, you will learn how Cancer Research Horizons can support you translate your research findings into cancer treatments and diagnostic tools through: 

Grant funding to progress drugs, devices, diagnostics, data and software

Seed and venture capital funds

Access to therapeutic discovery and development capabilities and expertise

Collaborations and alliances with industrial partners

Commercialisation of assets and tools

Entrepreneurial training programmes

Date of webinar: 12th February 2024, 13:00– 14:30 (GMT)

In this webinar, you will learn about: 

The CRH-Karolinska Institute Alliance by Richard Cowburn, KI

SciLifeLab DDD – a national infrastructure for academic Drug Discovery in Sweden, Per Arvidsson, SciLifeLab DDD

Why selecting the right target matters, Kristian Sandberg, SciLifeLab DDD

What makes a good target and how to validate it?, Stuart Farrow, CRH

Followed by a panel discussion and Q&A – What makes a good academic drug discovery program? 

Moderator: Per Arvidsson, SciLifeLab DDD, Panelists: Mikael Lindström, KI, Simon Cook, Bahabram Institute, Kristian Sandberg, SciLifeLab DDD, Stuart Farrow, CRH, Richard Cowburn, KI

On the 15th of June 2023 the partnership launch event took place in Innomdicum auditorium DaggkaÌŠpan at Nanna Svartz väg 4. Read more about the event  here.